Improving Compliance With Metformin

This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00018616
First received: July 3, 2001
Last updated: September 21, 2009
Last verified: September 2009
  Purpose

This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.


Condition Intervention Phase
Diabetes
Behavioral: MEMS caps
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Improving Compliance With Metformin

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Enrollment: 79
Study Start Date: October 1999
Study Completion Date: January 2005
Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1 Behavioral: MEMS caps

Detailed Description:

The active intervention, MEMS Feedback, involves review of patients' medication-taking over the preceding weeks

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Metformin has been prescribed
  • Willing to use medication containers with MEMS caps
  • Capable of giving informed consent

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018616

Locations
United States, Connecticut
VA Connecticut Health Care System (West Haven)
West Haven, Connecticut, United States, 06516
Sponsors and Collaborators
Investigators
Principal Investigator: Marc I. Rosen, MD VA Connecticut Health Care System (West Haven)
  More Information

No publications provided

Responsible Party: Rosen, Marc - Principal Investigator, Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018616     History of Changes
Other Study ID Numbers: MHBS-047-98F
Study First Received: July 3, 2001
Last Updated: September 21, 2009
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
compliance
MEMS
metformin

Additional relevant MeSH terms:
Metformin
Hypoglycemic Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 22, 2014